-
Halia Therapeutics to Present at Asia BIO 2024
17 Apr 2024 14:00 GMT
… ) 942-5604
Ignacio.Guerrero-Ros@russopartnersllc.com
View original content to download …
-
Independent Studies Presented at ESCMID Global Demonstrate the Clinical Utility of SeptiCyte® RAPID in Patients Suspected of Sepsis, Including in Polytrauma Patients
17 Apr 2024 14:00 GMT
…
Russo Partners, LLC
Madeline.stabinski@russopartnersllc.com
View original content to download …
-
Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting
16 Apr 2024 20:01 GMT
… , LLC
Ignacio.guerrero-ros@russopartnersllc.com
David.schull@russopartnersllc.com
(858) 717-2310 Investor …
-
Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting
15 Apr 2024 21:01 GMT
… (646) 942-5603
adanna.alexander@russopartnersllc.com Ignacio Guerrero-Ros, Ph.D … ) 942-5604
ignacio.guerrero-ros@russopartnersllc.com
-
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office
11 Apr 2024 13:31 GMT
…
(347) 956-7697
Elizabeth.phillips@russopartnersllc.com
-
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health
10 Apr 2024 13:57 GMT
… Contact
Scott Stachowiak
Scott.Stachowiak@russopartnersllc.com
+1-646-942-5630
View …
-
Zevra Therapeutics Refinances Existing Debt with up to $100M in Committed Capital under New Credit Facility
10 Apr 2024 11:30 GMT
… (646) 942-5603
adanna.alexander@russopartnersllc.com Ignacio Guerrero-Ros, Ph.D … ) 942-5604
ignacio.guerrero-ros@russopartnersllc.com
-
BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer’s Dementia
10 Apr 2024 11:00 GMT
… .858.717.2310
David.schull@russopartnersllc.com
Scott Stachowiak
1.646.942 … .5630
Scott.stachowiak@russopartnersllc.com Source: BioXcel Therapeutics, Inc. IGALMI …
-
Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer
08 Apr 2024 13:25 GMT
… and Elio Ambrosio
nic.johnson@russopartnersllc.com
elio.ambrosio@russopartnersllc.com
(212) 845-4242
-
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA
04 Apr 2024 13:31 GMT
…
(347) 956-7697
Elizabeth.phillips@russopartnersllc.com General Inquiries:
info@fibrobiologics.com